Table 3. Relationship between ADAMTS6 expression and patient characteristics.
| Characteristics | ADAMTS6 IHC score | |
|---|---|---|
| Mean ± SD | P | |
| Age (years) | 0.001* | |
| ≤56 | 38.48±31.903 | |
| >56 | 23.77±23.941 | |
| TNM stage | 0.004* | |
| I + II | 39.93±31.408 | |
| III + IV | 22.39±19.667 | |
| Diameter (cm) | 0.081 | |
| ≤7 | 26.48±26.265 | |
| >7 | 34.98±30.830 | |
| N stage | 0.974 | |
| Absent | 32.51±29.791 | |
| Present | 31.72±28.251 | |
| M stage | 0.228 | |
| Absent | 32.51±29.791 | |
| Present | 17.69±15.313 | |
| Histological grade | 0.670 | |
| I + II | 30.63±30.460 | |
| III | 32.70±29.041 | |
| Histological type | 0.636 | |
| Serous carcinoma | 33.60±27.630 | |
| Mucinous carcinoma | 31.21±30.384 | |
*, P<0.01. IHC, immunohistochemistry; TNM, tumor-node-metastasis; SD, standard deviation.